Project Grant F32AI194514
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $498,760 Cooperative Agreement to The Leland Stanford Junior University (Stanford University) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The 5-year project, running from Aug 2025 to Jun 2030, will investigate the role of innate allorecognition - the sensing of human leukocyte antigen (HLA) in kidney transplant grafts by killer Ig-like receptors (KIR) and leukocyte Ig-like...
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $606,609 Cooperative Agreement to the University of California, San Diego (UCSD) to conduct research on "T Cell Alloreactivity and Organ Transplant Risk Stratification Models Using High-Resolution HLA and Genomic Data." This grant, which runs from August 1, 2025 to July 31, 2030, is funded under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research aims to enhance understanding of...
- The Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $152,324 to The Leland Stanford Junior University to define the role of CXCL13 as an aging-associated defect in memory T cell homeostasis. The project, led by Dr. Casey Beppler, will leverage human immune organoid technology to reveal the mechanism of CXCL13-mediated maintenance of memory T cells (Aim 1) and determine the specific T cell...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Georgetown University a $429,000 Project Grant to conduct research on "Cell-Type-Specific Evaluation of Liver Allografts During Normothermic-Machine-Perfusion." The grant, awarded under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to advance the use of normothermic machine perfusion (NMP) technology and cell-free methylated DNA (cfDNA) monitoring to assess the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $131,076 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Leland Stanford Junior University. The grant will fund research to systematically understand how evolutionary pressures from the human host and bacteriophages contribute to the genetic diversity of the Salmonella enterica pathogen. Key goals include expanding upon the grantee's established random barcoded transposon...
- The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research grant program (CFDA 93.855), awarded a $300,000 Project Grant to The Methodist Hospital Research Institute in Houston, TX. The grant project, titled "LDHA-Dependent T-Cell Effector Programs in Heart Transplantation", investigates the role of lactate dehydrogenase A (LDHA) in regulating the differentiation of T-cell effectors, which play a critical role in rejecting...
- This federal Project Grant award, valued at $459,439.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research aimed at improving the understanding of alloreactivity, the immune response that leads to acute cellular rejection of transplanted tissues. The research seeks to identify the specific peptide-HLA complexes recognized by alloreactive T cells, which could...
- This federal Project Grant award of $1,031,754.00, awarded on September 2, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), supports research at The Johns Hopkins University to develop clinically relevant pharmacologic and immunomodulatory strategies to achieve long-term survival of kidney xenografts in primates. The research aims to advance understanding and treatment of infectious diseases and immune system disorders,...
- The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $1,135,986 Project Grant to Northwestern University. The grant, effective January 1, 2025, aims to identify cellular and molecular targets for developing tissue/cell-specific strategies to prevent cytomegalovirus (CMV) reactivation and improve outcomes in kidney transplant recipients. The research will investigate the role of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $164,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Albany Medical College. The grant supports research to identify and characterize additional conformer-specific anti-I-A monoclonal antibodies (mAbs) to study the structure and function of MHC class II molecules, which are important for T cell-mediated immune responses. The research aims to address limitations in existing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $153,512 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Leland Stanford Junior University. The grant will fund research to characterize the renal immune microenvironment in antibody-mediated rejection (ABMR) of kidney transplants in order to develop improved diagnostics and predict treatment response. The research will utilize advanced imaging mass cytometry to profile immune cell phenotypes, functions, and spatial distributions within kidney tissue biopsies. This data will be integrated with clinical variables to develop predictive models for ABMR treatment response. The project period runs from December 13, 2025 to June 30, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $76.8k | 6/13/25 | ||
| Not listed | $0 | 6/13/25 | ||
| Not listed | $76.8k | 6/13/25 |